share_log

A Closer Look at Merck & Co's Options Market Dynamics

A Closer Look at Merck & Co's Options Market Dynamics

默沙東的期權市場動態詳細解析
Benzinga ·  06/27 15:49

Whales with a lot of money to spend have taken a noticeably bullish stance on Merck & Co.

花大錢的鯨魚們對默沙東採取了明顯的看好態度。

Looking at options history for Merck & Co (NYSE:MRK) we detected 23 trades.

查看默沙東 (NYSE:MRK) 的期權歷史記錄,我們發現有 23 筆交易。

If we consider the specifics of each trade, it is accurate to state that 56% of the investors opened trades with bullish expectations and 34% with bearish.

如果我們考慮每筆交易的具體情況,可以準確地說,56% 的投資者帶着看好的預期開倉,而34% 則是看淡。

From the overall spotted trades, 12 are puts, for a total amount of $742,508 and 11, calls, for a total amount of $434,384.

從所有被發現的交易中,有 12 筆是看跌期權,總金額爲 $742,508,而11 筆則是看漲期權,總金額爲 $434,384。

Predicted Price Range

預測價格區間

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $127.0 to $150.0 for Merck & Co over the recent three months.

根據交易活動情況,顯然主要投資者的目標價位是默沙東在最近三個月內的區間,從 $127.0 到 $150.0。

Volume & Open Interest Development

成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團(Alibaba Gr Hldgs)特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內,阿里巴巴集團(Alibaba Gr Hldgs)在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中,成交量和持倉量的波動情況。

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益,以給定的行權價格爲基礎。

This data can help you track the liquidity and interest for Merck & Co's options for a given strike price.

這些數據可以幫助你追蹤默沙東的期權在給定行權價格上的流動性和興趣。

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Merck & Co's whale activity within a strike price range from $127.0 to $150.0 in the last 30 days.

下圖展示了最近 30 天內,默沙東所有的期權交易活動中,所有看漲和看跌的成交量和未平倉合約變化情況,合約價格範圍爲 $127.0 到 $150.0。

Merck & Co Call and Put Volume: 30-Day Overview

默沙東的看漲和看跌成交量:30天概述

Options Call Chart

Noteworthy Options Activity:

值得注意的期權活動:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
MRK PUT TRADE BEARISH 08/16/24 $3.0 $2.99 $3.0 $130.00 $120.0K 9810
MRK PUT TRADE NEUTRAL 06/28/24 $2.95 $2.69 $2.8 $130.00 $97.9K 8265.0K
MRK PUT TRADE BULLISH 06/28/24 $1.02 $0.8 $0.85 $130.00 $85.0K 8261.6K
MRK PUT TRADE BULLISH 06/28/24 $1.73 $1.58 $1.57 $130.00 $78.5K 8263.5K
MRK CALL TRADE BULLISH 06/28/24 $0.79 $0.72 $0.78 $129.00 $77.2K 8281.0K
標的 看跌/看漲 交易類型 情緒 到期日 賣盤 買盤 價格 執行價格 總交易價格 未平倉合約數量 成交量
MRK 看跌 交易 看淡 08/16/24 $3.0 $2.99 $3.0 $130.00 $120.0K 9810
MRK 看跌 交易 中立 06/28/24 $2.95應翻譯爲$2.95 $2.69 $2.8 $130.00 $97.9K 8265.0K
MRK 看跌 交易 看好 06/28/24 $1.02 $0.8 $0.85 $130.00 $85.0K 8261.6K
MRK 看跌 交易 看好 06/28/24 $1.73 $1.58 $1.57 $130.00 $78.5K 8263.5K
MRK 看漲 交易 看好 06/28/24 $0.79 0.72美元 $0.78 $129.00 $77.2K 8281.0K

About Merck & Co

關於默沙東

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

默沙東生產多種藥品,治療多種領域的疾病,包括心代謝症、癌症和感染。在癌症領域,該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務,包括預防兒童疾病以及人類乳頭瘤病毒(HPV)治療。此外,默沙東出售與動物健康相關的藥品。從地理角度來看,公司銷售額的近一半來自於美國境內。

After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

在對默沙東進行全面審查其期權交易後,我們進行更詳細的公司評估。這包括對其當前市場狀態和表現的評估。

Current Position of Merck & Co

默沙東目前的位置

  • Currently trading with a volume of 7,206,232, the MRK's price is up by 0.38%, now at $132.0.
  • RSI readings suggest the stock is currently may be approaching overbought.
  • Anticipated earnings release is in 33 days.
  • 交易量爲 7,206,232 的 MRK 價格上漲了 0.38%,現在爲 $132.0。
  • RSI讀數表明該股目前可能接近超買水平。
  • 預計業績發佈還有33天。

What Analysts Are Saying About Merck & Co

關於默沙東的分析師觀點

A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $155.0.

過去 30 天內,共有 3 名專業分析師對這家公司發表了觀點,設定了平均目標價爲 $155.0。

  • In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $155.
  • In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $155.
  • Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $155.
  • 一個來自Cantor Fitzgerald的分析師採取謹慎舉措,將其評級從“增持”降級爲“超配”,設置了155美元的目標價。
  • 一個來自Cantor Fitzgerald的分析師採取謹慎舉措,將其評級從“增持”降級爲“超配”,設置了155美元的目標價。
  • 反映擔憂,來自 Cantor Fitzgerald 的分析師將其評級下調爲增持,設定了新的價格目標爲 $155。

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.

期權交易涉及更大的風險,但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性交易調整、利用各種因子和關注市場動態來降低這些風險。使用 Benzinga Pro 獲取默沙東的最新期權交易實時警報。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論